Home › Therapeutic areas › Immunology › ANCA-Associated Vasculitis
ANCA-Associated Vasculitis (2 companies)
Companies with an active program in ANCA-Associated Vasculitis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ACET | Adicet Bio | ImmunologyNeurology+2 Rare | 1 | Phase 1 | $28.6M | 8 |
| NKTX | Nkarta | ImmunologyNeurology+1 Rare | 1 | Phase 1 | $124M | 8 |
No companies match.